March 24, 2022
The University of Cincinnati is enrolling patients for a new clinical trial testing a two-pronged immunotherapy approach to treat glioblastomas, deadly brain tumors.
March 29, 2022
CureToday highlighted the University of Cincinnati's new glioblastoma immunotherapy trial in a recent article.
May 5, 2023
The University of Cincinnati's Soma Sengupta was a co-first author on research published in Cell Reports Medicine New that found that a cancer stem cell test can accurately decide more effective treatments and lead to increased survival for patients with glioblastoma, a deadly brain tumor.
February 3, 2022
Scientists using 20 years of research to lessen the impact of brain injury
October 14, 2022
The University of Cincinnati's Soma Sengupta, MD, PhD, joined the Five to Thrive Live podcast to discuss "Humanizing Brain Tumors."
November 16, 2023
The University of Cincinnati Gardner Neuroscience Institute's Brandon Foreman recently published survey results identifying areas of consensus and needs for further research to develop a standard practice for comprehensively monitoring brain health in the intensive care unit.
April 1, 2024
The University of Cincinnati's Brandon Foreman joined the iHeart Cinci Podcast to discuss traumatic brain injuries, including signs to look for and how to discuss the topic with your doctor.
May 3, 2023
Laura Ngwenya, MD, PhD, was awarded research grants from the National Institute of Health and Department of Defense
August 27, 2021
UC research examining a music app to help breast cancer survivors is mentioned by Forbes.
September 23, 2022
The University of Cincinnati's Pankaj Desai, PhD, has received a $1.19 million grant from the National Institutes of Health/National Institute of Neurological Disorders and Stroke to continue research into the use of a drug called letrozole to treat glioblastomas, the most deadly form of brain tumors.